HALLE/SAALE, Germany, 7 March 2016 – Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), will publish its Full Year Results for 2015 on Tuesday, March 15, 2016. The company will host a conference call open to the public on March 15, 2016, at 15:00 Central European Time (CET).
The Full Year 2015 Results will be available for download on the company website
(http://www.probiodrug.de/investors/reports-and-presentations/).
###
For more information please contact:
Probiodrug
Dr Konrad Glund, CEO
Email: contact@probiodrug.de
Hume Brophy
Mary Clark, Supriya Mathur, Eva Haas
Tel: +44 (0) 207 862 6475
Email: probiodrug@humebrophy.com
The Trout Group
Tricia Truehart
Tel: +1 646 378-2953
Email: ttruehart@troutgroup.com
